Multiple endocrine neoplasia type 1: latest insights
ML Brandi, SK Agarwal, ND Perrier, KE Lines… - Endocrine …, 2021 - academic.oup.com
Multiple endocrine neoplasia type 1 (MEN1), a rare tumor syndrome that is inherited in an
autosomal dominant pattern, is continuing to raise great interest for endocrinology …
autosomal dominant pattern, is continuing to raise great interest for endocrinology …
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)
RV Thakker, PJ Newey, GV Walls… - The Journal of …, 2012 - academic.oup.com
Objective: The aim was to provide guidelines for evaluation, treatment, and genetic testing
for multiple endocrine neoplasia type 1 (MEN1). Participants: The group, which comprised …
for multiple endocrine neoplasia type 1 (MEN1). Participants: The group, which comprised …
Primary hyperparathyroidism
JP Bilezikian, NE Cusano, AA Khan, JM Liu… - Nature reviews Disease …, 2016 - nature.com
Primary hyperparathyroidism (PHPT) is a common disorder in which parathyroid hormone
(PTH) is excessively secreted from one or more of the four parathyroid glands. A single …
(PTH) is excessively secreted from one or more of the four parathyroid glands. A single …
[HTML][HTML] Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
RV Thakker - Molecular and cellular endocrinology, 2014 - Elsevier
Multiple endocrine neoplasia (MEN) is characterized by the occurrence of tumors involving
two or more endocrine glands within a single patient. Four major forms of MEN, which are …
two or more endocrine glands within a single patient. Four major forms of MEN, which are …
MEN4 and CDKN1B mutations: the latest of the MEN syndromes
R Alrezk, F Hannah-Shmouni… - Endocrine-related …, 2017 - erc.bioscientifica.com
Multiple endocrine neoplasia (MEN) refers to a group of autosomal dominant disorders with
generally high penetrance that lead to the development of a wide spectrum of endocrine and …
generally high penetrance that lead to the development of a wide spectrum of endocrine and …
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers
LC Hernández-Ramírez, P Gabrovska… - The Journal of …, 2015 - academic.oup.com
Context: Familial isolated pituitary adenoma (FIPA) due to aryl hydrocarbon receptor
interacting protein (AIP) gene mutations is an autosomal dominant disease with incomplete …
interacting protein (AIP) gene mutations is an autosomal dominant disease with incomplete …
Gut microbiota and diet in patients with different glucose tolerance
L Egshatyan, D Kashtanova, A Popenko… - Endocrine …, 2016 - ec.bioscientifica.com
Elevated C-terminal fibroblast growth factor 23 (C-FGF23) concentrations have been
reported in Gambian children with and without putative Ca-deficiency rickets. The aims of …
reported in Gambian children with and without putative Ca-deficiency rickets. The aims of …
Clinical features of multiple endocrine neoplasia type 4: novel pathogenic variant and review of published cases
A Frederiksen, M Rossing, P Hermann… - The Journal of …, 2019 - academic.oup.com
Context The clinical phenotype of multiple endocrine neoplasia type 4 (MEN4) is undefined
due to a limited number of published cases. Knowledge on disease manifestation in MEN4 …
due to a limited number of published cases. Knowledge on disease manifestation in MEN4 …
Multiple endocrine neoplasia type 4
M Lee, NS Pellegata - Endocrine Tumor Syndromes and Their Genetics, 2013 - karger.com
A few years ago a novel multiple endocrine neoplasia syndrome, named multiple endocrine
neoplasia type 4 (MEN4), was discovered thanks to studies conducted on a MEN syndrome …
neoplasia type 4 (MEN4), was discovered thanks to studies conducted on a MEN syndrome …
[HTML][HTML] The causes and consequences of pituitary gigantism
In the general population, height is determined by a complex interplay between genetic and
environmental factors. Pituitary gigantism is a rare but very important subgroup of patients …
environmental factors. Pituitary gigantism is a rare but very important subgroup of patients …